159 related articles for article (PubMed ID: 36550419)
1. Synthesis, characterization, and anticancer evaluation of 1,3-bistetrahydrofuran-2yl-5-FU as a potential agent for pancreatic cancer.
Ndemazie NB; Inkoom A; Ebesoh D; Bulusu R; Frimpong E; Trevino J; Han B; Zhu X; Agyare E
BMC Cancer; 2022 Dec; 22(1):1345. PubMed ID: 36550419
[TBL] [Abstract][Full Text] [Related]
2. Development of novel pyrimidine nucleoside analogs as potential anticancer agents: Synthesis, characterization, and In-vitro evaluation against pancreatic cancer.
Frimpong E; Bulusu R; Okoro J; Inkoom A; Ndemazie N; Rogers S; Zhu X; Han B; Agyare E
Eur J Pharm Sci; 2024 May; 196():106754. PubMed ID: 38554983
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Anticancer Activity of Zhubech, a New 5-FU Analog Liposomal Formulation, against Pancreatic Cancer.
Ndemazie NB; Bulusu R; Zhu XY; Frimpong EK; Inkoom A; Okoro J; Ebesoh D; Rogers S; Han B; Agyare E
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901721
[TBL] [Abstract][Full Text] [Related]
4. Biological evaluation of novel gemcitabine analog in patient-derived xenograft models of pancreatic cancer.
Inkoom A; Ndemazie NB; Smith T; Frimpong E; Bulusu R; Poku R; Zhu X; Han B; Trevino J; Agyare E
BMC Cancer; 2023 May; 23(1):435. PubMed ID: 37179357
[TBL] [Abstract][Full Text] [Related]
5. Enhancing efficacy of gemcitabine in pancreatic patient-derived xenograft mouse models.
Inkoom A; Ndemazie N; Affram K; Smith T; Zhu X; Underwood P; Krishnan S; Ofori E; Han B; Trevino J; Agyare E
Int J Pharm X; 2020 Dec; 2():100056. PubMed ID: 33015617
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic effects of gemcitabine-loaded solid lipid nanoparticles in pancreatic cancer cells.
Affram KO; Smith T; Ofori E; Krishnan S; Underwood P; Trevino JG; Agyare E
J Drug Deliv Sci Technol; 2020 Feb; 55():. PubMed ID: 31903101
[TBL] [Abstract][Full Text] [Related]
7. 5-Fluorouracil or gemcitabine combined with adenoviral-mediated reintroduction of p16INK4A greatly enhanced cytotoxicity in Panc-1 pancreatic adenocarcinoma cells.
Halloran CM; Ghaneh P; Shore S; Greenhalf W; Zumstein L; Wilson D; Neoptolemos JP; Costello E
J Gene Med; 2004 May; 6(5):514-25. PubMed ID: 15133762
[TBL] [Abstract][Full Text] [Related]
8. Diltiazem potentiates the cytotoxicity of gemcitabine and 5-fluorouracil in PANC-1 human pancreatic cancer cells through inhibition of P-glycoprotein.
El-Mahdy HA; El-Husseiny AA; Kandil YI; Gamal El-Din AM
Life Sci; 2020 Dec; 262():118518. PubMed ID: 33011221
[TBL] [Abstract][Full Text] [Related]
9. 5-fluorouracil suppresses stem cell-like properties by inhibiting p38 in pancreatic cancer cell line PANC-1.
Zhao J; Shi X; Dong C; Liu R; Su L; Cao C
Folia Histochem Cytobiol; 2022; 60(1):55-65. PubMed ID: 35103981
[TBL] [Abstract][Full Text] [Related]
10. Everolimus and mycophenolate mofetil sensitize human pancreatic cancer cells to gemcitabine in vitro: a novel adjunct to standard chemotherapy?
Tuncyurek P; Mayer JM; Klug F; Dillmann S; Henne-Bruns D; Keller F; Stracke S
Eur Surg Res; 2007; 39(6):380-7. PubMed ID: 17700025
[TBL] [Abstract][Full Text] [Related]
11. Autophagy is needed for the growth of pancreatic adenocarcinoma and has a cytoprotective effect against anticancer drugs.
Hashimoto D; Bläuer M; Hirota M; Ikonen NH; Sand J; Laukkarinen J
Eur J Cancer; 2014 May; 50(7):1382-90. PubMed ID: 24503026
[TBL] [Abstract][Full Text] [Related]
12. Schedule-dependent therapeutic effects of gemcitabine combined with uracil-tegafur in a human pancreatic cancer xenograft model.
Tsujie M; Nakamori S; Nakahira S; Takeda S; Takahashi Y; Hayashi N; Okami J; Nagano H; Dono K; Umeshita K; Sakon M; Monden M
Pancreas; 2006 Aug; 33(2):142-7. PubMed ID: 16868479
[TBL] [Abstract][Full Text] [Related]
13. Novel pyrazole-based COX-2 inhibitors as potential anticancer agents: Design, synthesis, cytotoxic effect against resistant cancer cells, cell cycle arrest, apoptosis induction and dual EGFR/Topo-1 inhibition.
Halim PA; Sharkawi SMZ; Labib MB
Bioorg Chem; 2023 Feb; 131():106273. PubMed ID: 36444790
[TBL] [Abstract][Full Text] [Related]
14. Antihepatoma peptide, scolopentide, derived from the centipede scolopendra subspinipes mutilans.
Hu YX; Liu Z; Zhang Z; Deng Z; Huang Z; Feng T; Zhou QH; Mei S; Yi C; Zhou Q; Zeng PH; Pei G; Tian S; Tian XF
World J Gastroenterol; 2023 Mar; 29(12):1875-1898. PubMed ID: 37032730
[TBL] [Abstract][Full Text] [Related]
15. A feasibility study on gene therapy of pancreatic carcinoma with Ad-PUMA.
Wang H; Pei W; Luan Q; Ma F; Zhou S; Zhao Z; Meng X; Zhang X; Liang X; Chen Y; Zhan Q; Lin C; Qian H; Zhao P
Cancer Biol Ther; 2012 Jul; 13(9):712-9. PubMed ID: 22617775
[TBL] [Abstract][Full Text] [Related]
16. Berberine induces apoptosis via ROS generation in PANC-1 and MIA-PaCa2 pancreatic cell lines.
Park SH; Sung JH; Kim EJ; Chung N
Braz J Med Biol Res; 2015 Feb; 48(2):111-9. PubMed ID: 25517919
[TBL] [Abstract][Full Text] [Related]
17. Combined treatment with tamoxifen and a fusicoccin derivative (ISIR-042) to overcome resistance to therapy and to enhance the antitumor activity of 5-fluorouracil and gemcitabine in pancreatic cancer cells.
Miyake T; Honma Y; Urano T; Kato N; Suzumiya J
Int J Oncol; 2015 Jul; 47(1):315-24. PubMed ID: 25936828
[TBL] [Abstract][Full Text] [Related]
18. Anacardic acid inhibits pancreatic cancer cell growth, and potentiates chemotherapeutic effect by Chmp1A - ATM - p53 signaling pathway.
Park M; Upton D; Blackmon M; Dixon V; Craver S; Neal D; Perkins D
BMC Complement Altern Med; 2018 Feb; 18(1):71. PubMed ID: 29463243
[TBL] [Abstract][Full Text] [Related]
19. Deferasirox, a novel oral iron chelator, shows antiproliferative activity against pancreatic cancer in vitro and in vivo.
Harima H; Kaino S; Takami T; Shinoda S; Matsumoto T; Fujisawa K; Yamamoto N; Yamasaki T; Sakaida I
BMC Cancer; 2016 Aug; 16(1):702. PubMed ID: 27582255
[TBL] [Abstract][Full Text] [Related]
20. Enriched environment housing enhances the sensitivity of mouse pancreatic cancer to chemotherapeutic agents.
Wu Y; Gan Y; Yuan H; Wang Q; Fan Y; Li G; Zhang J; Yao M; Gu J; Tu H
Biochem Biophys Res Commun; 2016 Apr; 473(2):593-9. PubMed ID: 27033603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
